Related Subjects:
|Drug Toxicity - clinical assessment
|Metabolic acidosis
|Aspirin or Salicylates toxicity
|Ethylene glycol toxicity
|Ethanol toxicity
|Methanol toxicity
|Ricin toxicity
|Carbon Tetrachloride Toxicity
|Renal Tubular Acidosis
|Lactic acidosis
|Iron Toxicity
|Tricyclic Antidepressant Toxicity
|Opiate Toxicity
|Carbon monoxide Toxicity
|Benzodiazepine Toxicity
|Paracetamol (Acetaminophen) toxicity
|Amphetamine toxicity
|Beta Blocker toxicity
|Calcium channel blockers toxicity
|Cannabis toxicity
|Cyanide toxicity
|Digoxin Toxicity
|Lithium Toxicity
|NSAIDS Toxicity
|Ecstasy toxicity
|Paraquat toxicity
|Quinine toxicity
|SSRI Toxicity
|Theophylline Toxicity
|Organophosphate (OP) Toxicity
|Toxin elimination by dialysis
|Drug Toxicity with Specific Antidotes
π Paracetamol Overdose: Clinical Management Guide
π¨ Critical: N-acetylcysteine (NAC) is almost 100% protective if given within 8 hours.
π Overview
- Most common cause of acute liver failure in the UK & Europe.
- Accounts for up to 50% of all poisonings presenting to ED.
- Lethal dose usually 12β15 g, but toxicity possible at lower doses with risk factors.
- Clinical outcomes depend more on **timing** of NAC than on the absolute dose ingested.
𧬠Pathophysiology
- Normal metabolism: ~90% undergoes safe glucuronidation/sulphation, ~5β10% β CYP2E1 β NAPQI.
- Glutathione neutralises NAPQI. Liver stores ~30 mg/kg glutathione β rapidly depleted in overdose.
- NAPQI binds hepatocellular proteins β mitochondrial dysfunction, oxidative stress, necrosis.
- In severe cases: systemic inflammatory response, renal tubular necrosis, multi-organ failure.
Risk Factors Mechanisms:
- πΊ Chronic alcohol β induces CYP2E1, β glutathione β β NAPQI.
- π½οΈ Malnutrition/fasting β low glutathione reserves.
- π₯ Chronic liver disease β impaired detoxification capacity.
- π Enzyme inducers (rifampicin, carbamazepine, phenytoin) β accelerate toxic metabolism.
Mnemonic MAL: Malnutrition, Alcohol, Liver disease β high risk of severe toxicity.
π Clinical Course
| Phase | Time | Clinical Features | Pathophysiology |
| 1 | 0β24h |
Nausea, vomiting, pallor, sweating; may be asymptomatic |
Drug absorption, no hepatotoxicity yet |
| 2 | 24β72h |
RUQ pain, βAST/ALT, hepatomegaly, tenderness |
Hepatocellular injury, rising transaminases |
| 3 | 72β96h |
Jaundice, encephalopathy, coagulopathy, hypoglycaemia, lactic acidosis |
Fulminant hepatic failure, systemic complications |
| 4 | 4β14d |
Recovery if liver regenerates OR progression to death/transplant |
Resolution or irreversible necrosis |
π¬ Investigations
- π Plasma paracetamol level: only valid β₯4h post ingestion; plot on Rumack-Matthew nomogram.
- π§ͺ LFTs: ALT/AST often peak 72β96h, may exceed 10,000 IU/L in severe toxicity.
- π©Έ INR/PT: best marker of synthetic failure; prolonged INR = poor prognosis.
- π« ABG/VBG: metabolic acidosis β indicates mitochondrial dysfunction, poor outcome.
- π« Renal function: creatinine rise suggests concurrent acute kidney injury.
- π§ Glucose monitoring: hypoglycaemia due to impaired gluconeogenesis.
Interpretation tip: Normal LFTs early on do not exclude significant toxicity.
π Management Principles
- Airway, breathing, circulation β stabilise first.
- Identify time & dose of ingestion; always consider staggered ingestions.
- Charcoal and NAC are complementary: charcoal reduces absorption, NAC repairs metabolism.
Activated Charcoal
- Indicated if within 1h of ingestion β₯150 mg/kg.
- 50 g orally/NG tube if patient alert or airway protected.
- Not given if vomiting, drowsy, or aspiration risk.
NAC Indications (UK)
- Plasma paracetamol above single treatment line (100 mg/L at 4h).
- β₯150 mg/kg ingestion where level not yet available.
- Presentation >24h with detectable paracetamol OR any liver injury (βALT, INR>1.3, jaundice).
NAC Mechanism
- Replenishes glutathione β detoxifies NAPQI.
- Improves hepatic microcirculation, acts as antioxidant.
- Remains effective even if given late, though best within 8h.
NAC Regimen (3-bag, IV)
- Bag 1: 150 mg/kg in 200 mL over 1h
- Bag 2: 50 mg/kg in 500 mL over 4h
- Bag 3: 100 mg/kg in 1L over 16h
π‘ Use ceiling weight of 110 kg for obese patients.
NAC Adverse Effects
- Rash/flushing (common, mild) β continue.
- Anaphylactoid reaction (bronchospasm, hypotension) β stop temporarily, give antihistamine, restart slowly.
π Prognosis
Poor prognostic indicators (Mnemonic: PHAIL):
- PH <7.3 (arterial)
- High INR β₯100s
- Azotaemia (Creatinine β₯300 Β΅mol/L)
- INR rising despite NAC
- Liver encephalopathy (Grade III/IV)
β‘οΈ Criteria for urgent liver transplant referral: INR β₯3, encephalopathy, metabolic acidosis, renal failure.
β οΈ Complications
- Fulminant hepatic failure (risk of cerebral oedema, sepsis, multiorgan failure)
- Acute kidney injury (tubular necrosis, often delayed)
- Lactic acidosis (poor prognostic marker)
πΆ Special Cases
- Pregnancy: NAC safe; protects both mother & fetus. Delay worsens outcomes for both.
- Staggered ingestion: Nomogram not applicable; treat if dose β₯75 mg/kg in 24h OR any liver injury.
- Chronic ingestion: Consider NAC if symptomatic or abnormal LFT/INR.
- Co-ingestions: Salicylates, opioids, benzodiazepines β alter presentation and management.
π Quick Revision Checklist
- β° Establish time & dose ingested.
- π Take paracetamol level (β₯4h).
- π§ͺ Check LFTs, INR, glucose, VBG.
- π€ Charcoal if <1h and airway safe.
- π Start NAC if indicated.
- π Refer to liver unit if PHAIL features present.
π§ββοΈ Case 1: Early Presentation (Safe Window)
A 20-year-old student presents 3 hours after taking 20 Γ 500 mg paracetamol tablets following an argument with her partner. She has mild nausea but is alert and stable. Past medical history unremarkable.
- Total dose: 10 g (~160 mg/kg for 62 kg patient)
- Action: Too early for paracetamol level (needs β₯4h). Admit, monitor, repeat bloods at 4h.
- If 4h level above 100 mg/L line β start NAC.
- Learning point: Always wait until 4h for reliable levels, unless ingestion is staggered/uncertain.
π§ββοΈ Case 2: Delayed Presentation (High Risk)
A 35-year-old man arrives 14 hours after ingesting 25 g paracetamol (50 tablets). He reports ongoing vomiting and confusion. Examination: jaundiced sclera, RUQ tenderness.
- Total dose: 25 g (~300 mg/kg for 80 kg male)
- Investigations: Paracetamol level detectable; ALT 5,000; INR 2.4
- Management: Immediate NAC (do not wait for nomogram). Admit to HDU. Discuss with liver unit if INR rises to β₯3 or encephalopathy worsens.
- Learning point: Beyond 8h β always start NAC if significant ingestion; nomogram less useful late.
π§ββοΈ Case 3: Staggered Overdose
A 45-year-old woman with chronic back pain admits to taking β8β10 tablets every few hoursβ over the past 2 days (estimated 30 g total). She feels nauseated but not confused. Past history: fatty liver disease.
- Problem: No single ingestion time β nomogram not applicable.
- Action: Start NAC empirically, especially with risk factors (liver disease).
- Learning point: Staggered ingestions = treat if total dose β₯75 mg/kg in 24h or LFTs abnormal.
π§ββοΈ Case 4: Special Group β Pregnancy
A 26-year-old woman, 28 weeks pregnant, presents 5 hours after ingestion of 15 g paracetamol. She is well but anxious for the baby.
- Total dose: 15 g (~200 mg/kg)
- Action: Paracetamol level ordered at 4h; start NAC immediately if above line.
- Key point: NAC is safe in pregnancy β protects both mother and fetus. Do not delay.
π§ββοΈ Case 5: Poor Prognosis Indicators
A 40-year-old man presents 4 days after a massive overdose. He is jaundiced, confused, hypotensive, and oliguric.
- Results: pH 7.25, Creatinine 350 Β΅mol/L, INR 120, Grade III encephalopathy.
- Interpretation: Meets multiple βPHAILβ poor prognosis criteria.
- Action: Emergency referral to liver transplant unit; continue NAC until outcome decided.
π― Exam Tips
- NAC within 8h = protective (key exam fact).
- MAL = Risk factors (Malnutrition, Alcohol, Liver disease).
- PHAIL = Poor prognosis β transplant referral.
- Common OSCE station: βPlot on nomogram β decide NAC β explain to patientβ.
π References